Restoril is a brand name for temazepam, a prescription medication belonging to the benzodiazepine class. It is a central nervous system (CNS) depressant primarily prescribed for the short-term treatment of severe insomnia, such as difficulty falling asleep or waking frequently during the night Because it carries a high risk of dependence and misuse, it is classified as a controlled substance and is intended only for brief periods of use • Primary Use: Short-term management of insomnia, usually limited to 7 to 10 days. It works by slowing down brain and nerve activity to produce a calming effect.
• Onset and Duration: It acts rapidly, taking effect within 30 minutes, and its sleep-inducing impact can last for up to 8 hours.
• Dosage Forms: It is typically administered orally as a capsule. Common strengths include 7.5 mg, 15 mg, 22.5 mg, and 30 mg Adults (under 65): The standard dose is 15 mg taken once daily immediately before going to bed. Depending on individual needs, doctors may adjust this from 7.5 mg to 30 mg Older Adults (65+): Healthcare providers generally recommend a lower initial dose of 7.5 mg at bedtime to minimize the risks of over-sedation, confusion, or falls.